NCT04687865 Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)
| NCT ID | NCT04687865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Organ Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2020-01-08 |
| Primary Completion | 2040-01-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2020-01-08 with a primary completion date of 2040-01-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order : i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)
Eligibility Criteria
Inclusion Criteria: * Male or Female patient ≥18 years old * Recipient of an organ transplant * Written informed consent Exclusion Criteria: * Non-affiliation to a social security system. * Subjects deprived of liberties * Pregnant or breastfeeding woman
Contact & Investigator
Olivier Thaunat, MD
PRINCIPAL INVESTIGATOR
Edouard Herriot Hospital - Transplantation department
Frequently Asked Questions
Who can join the NCT04687865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Organ Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04687865 currently recruiting?
Yes, NCT04687865 is actively recruiting participants. Contact the research team at olivier.thaunat@chu-lyon.fr for enrollment information.
Where is the NCT04687865 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT04687865 clinical trial?
NCT04687865 is sponsored by Hospices Civils de Lyon. The principal investigator is Olivier Thaunat, MD at Edouard Herriot Hospital - Transplantation department. The trial plans to enroll 4,000 participants.